Research.Patient.info
Apathy in neurodegenerative disorders research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A prospective, single-centre, randomised, double-blind, placebo-controlled, phase I, First-In-Human (FIH) trial evaluating the safety and tolerability of single and multiple ascending oral doses of IRL757 in healthy volunteers.
Sweden - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers
Sweden